Zobrazeno 1 - 10
of 22
pro vyhledávání: '"N. I. Lazareva"'
Autor:
I. Zh. Shubina, A. N. Gritsay, L. T. Mamedova, A. V. Sergeev, S. A. Kuznetsov, N. R. Pogosyan, N. I. Lazareva, M. V. Kiselevsky
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3, Pp 58-63 (2014)
More and more data suggest that ovarian cancer (OC) is an immunogenic tumor. Clinical trials dealing with immunotherapy based on activated natural killer (NK) cells and dendritic cells (DC) are under way. Mononuclear cells (MNCs) from both peripheral
Externí odkaz:
https://doaj.org/article/33f44cc9d1e04fb0a425da12421a3fbc
Autor:
I. R. Gagua, V. V. Kuznetzov, N. I. Lazareva, V. M. Nechushkina, T. I. Zakharova, Zh. A. Zavolskaya
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 1, Pp 45-51 (2014)
Surgery is the main method of treatment of the patients with the uterine leiomyosarcoma. A standard extent of surgery is extirpation of the uterus without its appendages in the reproductive period or with uterine appendages in the postmenopause. The
Externí odkaz:
https://doaj.org/article/a91159e7c5c04d32a2ab6b7463e42a0a
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3, Pp 88-94 (2014)
The review describes the etiology and clinical features of ovarian sarcomas and current approaches applied to their diagnosis and treatment.
Externí odkaz:
https://doaj.org/article/b7a7783b49c84cd299a7827d82af42e6
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 1-2, Pp 67-71 (2014)
The review of literature describes the etiology and clinical features of sarcomas of the cervix uteri and current approaches to their diagnosis and treatment.
Externí odkaz:
https://doaj.org/article/3b68876c0e844bc9a9d5fd9228ecf387
Autor:
I. Zh. Shubina, A. N. Gritsay, L. T. Mamedova, N. Yu. Sokolov, S. A. Kuznetsov, M. V. Kiselevskiy, N. I. Lazareva, V. V. Kuznetsov, K. S. Titov, A. P. Nikolayev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3-4, Pp 110-113 (2014)
In the last decade, accumulated evidence in favor of that ovarian cancer is an immunogenic tumor. Immunotherapy is aimed at stimulating the innate and adaptive immunity, may cause an effective response in patients with ovarian cancer. Various approac
Externí odkaz:
https://doaj.org/article/51e7701c947542b0be9c424fe49bca4e
Autor:
K. S. Titov, S. M. Volkov, L. V. Demidov, A. N. Gritsay, N. I. Lazareva, M. V. Kiselevskiy, A. P. Nikolayev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3-4, Pp 101-104 (2014)
Malignant pericardial effusions often arise in patients with breаst cancer and ovarian cancer. Sistem antitumor therapy is uneffective in gen- erally and causes side effects. Here we show that intrapericardial interleukin-2 with allogenеc lymphokin
Externí odkaz:
https://doaj.org/article/acbcba1d10864a0f941029fe597951e7
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3-4, Pp 88-92 (2014)
This review contains data on an aetiology, features of a clinical presentations and modern approaches in diagnostics and treatment of ovarian carcinosarcomas.
Externí odkaz:
https://doaj.org/article/afd603a6b43d4506b877b335f3d279f1
Autor:
I. V. Matrosova, I. A. Fainshtein, I. V. Poddubnaya, M. I. Nechushkin, N. I. Lazareva, N. V. Levitskaya, V. V. Kuznetsov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 2, Pp 73-76 (2014)
The results of treatment were studied in 95 patients with local recurrences of uterine sarcomas, who had been treated at the N.N. Blokhin Russian Cancer Research Center in 1972 to 2010. Two patient groups were comparatively analyzed after surgical an
Externí odkaz:
https://doaj.org/article/33a2955b1d6441059daceb7a2ac12f3c
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 2, Pp 68-70 (2014)
Leiomyomas predominate among benign nonepithelial tumors of the corpus uteri. According to the data available in the literature, they occur in 25% of women above 35 years of age and constitute 33% of all gynecological diseases. Leimyoma is commonly a
Externí odkaz:
https://doaj.org/article/824d071547dd446d9069b0af273cef3a
Publikováno v:
Voprosy onkologii. 44(5)
The data on treatment of 50 patients with endometrial stromal sarcoma (Ess) are discussed. Mean age-46.5 years. The group included 28 patients with stage I tumor, 7-stage II, 8-stage III and 7-stage IV. The end results of surgical, combined and compl